CYTOSORBENTS CORP
CTSO · NASDAQ
Updated at 2026-10-13 15:18:11
- Today's High
- $3.67
- Today’s Low
- $3.45
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $3.65
- Previous Close
- $3.58
- Volume
- 8.34K
- Market Cap
- $11.31M
- P/E Ratio
- --
- EPS
- $-0.29
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- MEDICAL DEVICES
- Headquarters
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, UNITED STATES, 08540
- Country
- US
- Listing Date
- 2005-06-17
- Fiscal Year End
- December
- Shares Outstanding
- 62.84M
- CIK
- 0001175151
- Website
- cytosorbents.com
Cytosorbents Corporation, a critical care focused immunotherapy company, is dedicated to the research, development and commercialization of medical devices with its blood purification technology platform incorporating proprietary adsorbent and porous polymer technology. The company is headquartered in Monmouth Junction, New Jersey.
Financial Metrics
Revenue
2026-06-30
$9.63M
2026-03-31
$8.86M
2025-12-31
$9.23M
2025-09-30
$9.48M
Operating Expenses
2026-06-30
$9.68M
2026-03-31
$9.17M
2025-12-31
$10.67M
2025-09-30
$9.52M
Net Income
2026-06-30
-$4.41M
2026-03-31
-$5.12M
2025-12-31
-$5.49M
2025-09-30
-$3.17M
Net Profit Margin
2026-06-30
-45.85%
2026-03-31
-57.86%
2025-12-31
-59.53%
2025-09-30
-33.42%
Earnings Per Share
2026-06-30
$-0.07
2026-03-31
$-0.08
2025-12-31
$-0.09
2025-09-30
$-0.05
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.17M
2026-03-31
-$3.89M
2025-12-31
-$4.36M
2025-09-30
-$2.52M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
11.22%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $9.63M | $8.86M | $9.23M | $9.48M |
| Operating Expenses | $9.68M | $9.17M | $10.67M | $9.52M |
| Net Income | -$4.41M | -$5.12M | -$5.49M | -$3.17M |
| Net Profit Margin | -45.85% | -57.86% | -59.53% | -33.42% |
| Earnings Per Share | $-0.07 | $-0.08 | $-0.09 | $-0.05 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.17M | -$3.89M | -$4.36M | -$2.52M |
| Effective Tax Rate | -- | -- | -- | 11.22% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.